Research location
Maxéville
France
Advertisement
Research activity in Maxéville
FranceCureCurrent currently publishes aggregate city-level research activity for this location: 8 trials and 9 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Maxéville
8 linked trials · page 1 of 1Evaluation of the Concordance Between Measures Obtained by a Medical Device for Emotional Monitoring (EMOCARE) and the Patient Health Questionnaire (PHQ-9) Score in Patients With Mild to Severe Depressive EpisodeNCT06601140 · 2025-03-05 · 1 site observation
RECRUITING
Impact of Reducing Antihypertensive Treatment on Mortality in Frail Subjects With Low Systolic Blood Pressure (SBP).NCT03453268 · 2018-10-02 · 2 site observations
COMPLETED
Evaluation of the Frequency of Limitation of Activity in Patients With Persistent AsthmaNCT01078688 · 2010-03-01 · 1 site observation
COMPLETED
National Survey on HypertensionNCT00804167 · 2008-12-01 · 1 site observation
COMPLETED
European Non-interventional Study in Chronic Obstructive Pulmonary Disease (COPD) PatientsNCT00722267 · 2008-07-01 · 1 site observation
COMPLETED
National Survey on Hypertension in General Practitioner (GP) ConsultationNCT00695656 · 2008-04-01 · 1 site observation
COMPLETED
Paclitaxel, Carboplatin, and Radiation Therapy With or Without Adjuvant Paclitaxel and Carboplatin in Treating Patients With Stage II or Stage III Unresectable Non-Small Cell Lung CancerNCT00077220 · 2002-06-01 · 1 site observation
UNKNOWN
Effects of a 9-months Treatment of SPIRIVA on Health Related Quality of Life in Patients With COPDNCT00274053 · 2002-04-01 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.